Table of Contents
Preface
I. Setting the scene and introductory chapters
1. Distribution of the endocannabinoid system: linking signalling and development Michaela Dvorakova and Anna Kalinovsky
2. The endocannabinoid system, immunomodulation, and LPS-induced inflammation Elliot Lloyd, Nina Nguyen and Judith Hellman
3. Physiology of the endocannabinoid systems: imaging and the use of positron emission tomography (PET) Claudia Poluga, Cassis Varlow, Neil Vasdev, Isabelle Boileau and Laura M. Best
4. The endocannabinoid system and aging Prof. Vahid Reza Askari
5. The endocannabinoid system and post traumatic stress disorder (PTSD): a new narrative Luke Ney, Kevin M. Crombie and Leah M. Mayo
II. Neurobiology of the endocannabinoid system
6. The protective effect of the endocannabinoid system in neurotoxin induced damage to hippocampal neurons: a focus on light and electron microscopy Rita Yakovlevna Gordon, Valentina Kitchigina and Irina Mikheeva
7. Endocannabinoid Signaling and excitatory and inhibitory synapses Jian Liang and Corette J. Wierenga
8. The endocannabinoids and potassium channels: an updated narrative Yu-Fung Lin
9. Social interactions and neural activity: linking cellular studies and endocannabinoid signalling Cheryl McCormick
10. Exercise and Parkinson's disease: linking in the cannabinoid type 1 (CB1) and type 2 (CB2), and mu-opioid receptors Marucia Chacur Sr., Caroline Cristiano Real Greg�rio and Karina Henrique Binda
11. Endocannabinoids and inhalant misuse: neuropsychological aspects John Woodward
12. Fatty acid amide hydrolase (FAAH) in substance use disorders: FAAH regulation and inhibition in cannabis, alcohol, nicotine, stimulant, and opioid use disorders Garth E. Terry and Greta Niemela
13. Treatment of pain with dual fatty acid amide hydrolase (FAAH) enzyme and human soluble epoxide hydrolase (sEH) enzyme inhibitors: interlinking the endocannabinoid system Stevan Pecic and Ram Kandasamy
14. WWL70: linking the hydrolyses 2-arachidonoylglycerol, endocannabinoid and eicosanoid pathways: therapeutic potential and neurological disease Mikiei Tanaka and Yumin Zhang
15. Endocannabinoid catabolic enzyme inhibitors and pain alleviation Sidney Stevens Negus and Clare Diester
16. The endocannabinoid system in health and disease: features in epilepsy Christopher Mart�nez-Aguirre, Maria de los Angeles Nu�ez-Lumbreras and Luisa Lilia Rocha
17. The endocannabinoid system and autoimmune demyelination: a focus on multiple sclerosis Ana Bernal-Chico, Andres Baraibar, Alvaro Moreno-Garcia, Teresa Colomer, Ester Sanchez, Carmen Utrilla, Carlos Matute and Susana Mato
18. Endocannabinoid signaling and the lateral habenula Jiang-Hong Ye
19. On the interplay among endocannabinoid, noradrenergic and glucocorticoid systems: evidence from aversive memory studies Mois�s Dos Santos Corr�a, Raquel Fornari, Cristina A. Stern, Leandro Jos� Bertoglio and Lucas Gazarini
III. Receptor biology and responses
20. Adenosine A2A-cannabinoid CB1 receptor heteromers in the brain: From trans-inhibition to trans-activation Ester Aso and Francisco Ciruela
21. Hippocampal CB1, CB2 receptors, the endocannabinoid system and fear memory Ana Maria Raymundi and Cristina A. Stern
22. Beta-caryophyllene, the CB2 cannabinoid receptor-specific agonists and wound healing Prof. S. Koyama and Thomas Heinbockel
23. The nigrostriatal dopaminergic pathway: impact of WIN 55212-2 as a potent cannaboinoid receptor agonist Enzo Perez-Valenzuela and Jose Antonio Fuentealba Evans
24. Peripheral cannabinoid receptor 1 antagonists and impact on adipocytes Morvarid Kabir
25. Endocannabinoid system receptors in plasma membranes : extraction, lipid rafts and the cortex Changiz Taghibiglou and Hajar Miranzadeh Mahabadi
26. Applications to wound healing: cannabinoid receptor 1 antagonism and collagen deposition In�s Correia-Sa
27. Role of the Transient Receptor Potential Vanilloid 1 (TRPV1), a component of the endocannabinoid system, in anxiety, depression, and cocaine addiction Carmen S. Maldonado-Vlaar and Wickensonn Norze
28. Allosteric modulators of the endocannabinoid system: Org27569 and cannabinoid receptor 1 (CB1) Dai Lu
29. Naturally occurring DELTA-9-tetrahydrocannabinol-derivatives and binding to CB1 and CB2 receptors: Linking in the endocannabinoid system Irene Reyes-Resina, Rafael Rivas-Santisteban, Iu Ra�ch, Claudia Llin�s del Torrent, Jaume Lillo, Rafael Franco and Gemma Navarro
IV. Profiles and behaviour of selective endocannabinoids
30. New cannabinoid receptor type 1 and 2 agonists and applications to understanding the endocannabinoid system Manuel Faundez-Parraguez
31. Fatty acid amide hydrolase, the endocannabinoid anandamide and neurological disease Filomena Fezza
32. The endocannabinoid-system in the immuno-biology of dendritic cells Dipyaman Ganguly
33. Palmitoylethanolamide and other anandamide congeners in neuroinflammation-based disorders: linking in the endocannabinoid system Enza Palazzo
34. Endocannabinoid modulation of synaptic function and behavior in the dorsomedial hypothalamus Karen M. Crosby
35. Key role of anandamide and the endocannabinoid system in the modulation of cardio-renal homeostasis Prof. Virna M. Mart�n Gimenez and Walter Manucha
36. The endocannabinoid system: Signaling and social motivation Roberta Monterazzo Cysneiros and Fernanda Ribeiro
V. Exogenous, synthetic other compounds linking in the endocannabinoid system
37. Safety and toxicology of the dietary cannabinoid beta-caryophyllene Prof. George Oliveira Sr., Bruna Silva, Ana Santos C. L. da Silva and Luciano Silva Lopes
38. Synthetic cannabimimetics: an overview Prof. M. Kassiou
VI. Compartive studies in non neurological systems
39. Non Neurological Aspects of the Endocannabinoid System: Non Alcoholic Fatty Liver Disease Dr. R. Ghazali
40. Components of the Endocannabinoid system: Hepatic expression levels of the cannabinoid receptors and microRNAs Sema Bolkent and Zeynep Mine Coskun
41. Tumour growth and the endocannabinoid system: investigating CB2 agonists Josee Guindon, Isabel Castro-Piedras, Melissa McHann and Robert Barnes
42. Linking Endocannabinoid System, Palmitoylethanolamide and Sarcopenia in view of therapeutic outcomes Susanna Molinari, Eleonora Maretti, Renata Battini and Eliana Leo
VII. Resources
43. Endocannabinoids and Resources Rajkumar Rajendram